ABSTRACT
Injection-site hypersensitivity Injection-site induration (13%) (2001): Ziemssen T+, Drug Saf 24(13), 979 Injection-site inflammation (49%) (2001): Ziemssen T+, Drug Sof 24(13), 979 Injection-site pain (73%) Injection-site pigmentation Injection-site pruritus (40%) Injection-site reactions (6.5%) (2002): Flechter S+, J Neurol Sci 197(1), 51 (67%) (2002): Ziemssen T+, Nervenarzt 73(4), 321 Injection-site urticaria (5%) Lipoatrophy (2001): Hwang L+, Cutis 68(4), 287 (1999): Drago F+, Arch Dermatol 135(10), 1277 (localized) Lipoma Lymphedema Mastodynia (>2%) Moon face Mouth vesiculation (6%) Myalgia (>2%) Myasthenia (>2%) Myasthenia gravis (2000): Frese A+, J Neurol 247(9), 713 Myopathy Oral candidiasis Oral ulceration Pain (28%) Paresthesias (>2%) Pharyngitis (>2%) Priapism Serum sickness Sinusitis (>2%) Stomatitis Tenosynovitis Tinnitus (>2%) Tongue edema Tongue pigmentation Trembling Tremor (7%) Tumors Ulcerative stomatitis Vaginitis Xerostomia (>2%)
